American journal of cardiovascular drugs : drugs, devices, and other interventions

GLP-1 Medicines and Heart Health in People with Type 2 Diabetes, Including Those Who Have Had Heart Attacks

Updated

Abstract

Patients with type 2 diabetes mellitus who survive myocardial infarction remain at high risk for recurrent cardiovascular events.

  • Survivors of myocardial infarction with type 2 diabetes have a notably high risk of heart failure.
  • Glucagon-like peptide-1 receptor agonists are associated with reduced cardiovascular events in patients with stable atherosclerotic disease.
  • The effects of glucagon-like peptide-1 receptor agonists on patients with established myocardial infarction have not been fully evaluated.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

0 of 11
authors report competing interests
11 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free